Brief: Vita Life Sciences Sees FY20 EBIT Increase By Around 75% From Prior Year
Dec 14 (Reuters) - Vita Life Sciences Ltd VLS.AX :
* SEES FY20 EBIT INCREASE BY AROUND 75% FROM PRIOR YEAR
* SEES EBIT FOR FY2020 WILL BE IN RANGE OF $5.5M TO $6.0M
* SEES FY20 SALES OF $45.5 MILLION - $46.0 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nASX9k03j0
Further company coverage: VLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vita Life Sciences
See all newsBrief: Vita Life Sciences Guides H1 Sales At A$46.3 Million-A$47.3 Million
Brief: Vita Life Sciences Sees Pre-Tax Profit A$6.2M-A$6.7M For Half Year
Australia's Vita Life Sciences slips on subdued earnings forecast
Brief: Vita Life Sciences Sees Half Year Sales Of A$39.0M-A$40.0M
Brief: Vita Life Sciences Delays Date To Hold AGM To 22 May